A randomized clinical trial of the impact of local estrogen on postoperative tissue quality after vaginal reconstructive surgery

Female Pelvic Medicine and Reconstructive Surgery

Volumn 18, Issue 4, 2012, Pages 211-215

  Karp, Deborah R ^a   Jean Michel, Marjorie ^b   Johnston, Yasmin ^c   Suciu, Gabriel ^d   Aguilar, Vivian C ^c   Davila, G Willy ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRONX LEBANON HOSPITAL CENTER   (United States)

^c DEPARTMENT OF COLORECTAL SURGERY   (United States)

^d NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

Atrophy; Estrogen replacement therapy; Pelvic reconstructive surgery; Postmenopausal; Wound healing

Indexed keywords

GRANULATION; TISSUE;

ATROPHY; ESTROGEN REPLACEMENT THERAPY; POSTMENOPAUSAL; RECONSTRUCTIVE SURGERY; WOUND HEALING;

QUALITY CONTROL;

ESTRADIOL; ESTROGEN;

AGED; ARTICLE; ATROPHY; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEASIBILITY STUDY; FEMALE; FEMALE CONTRACEPTIVE DEVICE; GRANULATION TISSUE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; MIDDLE AGED; PATHOLOGY; PELVIC ORGAN PROLAPSE; POSTOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VAGINA; WOUND HEALING;

ADMINISTRATION, INTRAVAGINAL; AGED; ATROPHY; COHORT STUDIES; CONTRACEPTIVE DEVICES, FEMALE; ESTRADIOL; ESTROGENS; FEASIBILITY STUDIES; FEMALE; GRANULATION TISSUE; HUMANS; MIDDLE AGED; PELVIC ORGAN PROLAPSE; POSTOPERATIVE CARE; TREATMENT OUTCOME; VAGINA; WOUND HEALING;

EID: 84864683643     PISSN: 21518378     EISSN: None     Source Type: Journal    
DOI: 10.1097/SPV.0b013e31825e6401     Document Type: Article

References (14)

1. The role of local vaginal estrogen for treatment of vaginal atrophy: 2007 position statement of The North American Menopause Society. Menopause. 2007;14(3):355-369.
2. Robinson D, Cardozo LD. The role of estrogens in female lower urinary tract dysfunction. Urology 2003;62(suppl 4A):45-51.
3. Greendale GA, Judd HL. The menopause: health implications and clinical management. J Am Geriatr Soc 1993;41:426-436.
4. Bachmann GA, Nevadunsky NS. Diagnosis and treatment of atrophic vaginitis. Am Fam Physician 2000;61:3090-3096.
5. Ramirez PT, Klemer DP. Vaginal evisceration after hysterectomy: a literature review. Obstet Gynecol Surv 2002;57(7):462-467.
6. Henriksson L, Stjernquist M, Boquist L, et al. A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging. Am J Obstet Gynecol 1996;174(1):85-92.
7. Bachmann GA, Lobo RA, Gut R. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Obstet Gynecol 2008;111(1):67-76.
8. Meisels A. The maturation value. Acta Cytol 1967;11:249-253.
9. Davila GW, Singh A, Karapanagiotou I, etal. Are women with urogenital atrophy symptomatic? Am J Obstet Gynecol 2003;188(2):382-388.
10. Brizzolara S, Killeen J, Severino R. Vaginal pH and parabasal cells in postmenopausal women. Obstet Gynecol 1999;94(5):700-703.
11. Casper F, Petri E. Local treatment of urogenital atrophy with an estradiol-releasing vaginal ring: a comparative and a placebo-controlled multicenter study. Int Urogynecol J 1999;10:171-176.
12. Barentsen R, van de Weijer PH, Schram JH. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. Eur J Obstet Gynecol 1997;71:73-80.
13. Eriksen BC. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring\) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 1999;180(5):1072-1079.
14. Sung VW, Rogers RG, Schaffer JI, et al. Graft use in transvaginal pelvic organ prolapse repair. Obstet Gynecol 2008;112(5):1131-1142.